Episode Summary
Executive Summary: The episode profiles retired British Army Brigadier General and bomb-disposal engineer Dr. Gareth Collett, tracing his path from military family roots to elite ordnance work in Northern Ireland, Iraq, and Afghanistan, then into academia and research. It highlights his technical methods, PTSD experience, and a personal cancer investigation suggesting a possible occupational link between bomb disposal and bladder/urological cancers.
Main Topics: Path into bomb disposal and military service (Priority: 5/5): Collett explains how the Hyde Park/Regent's Park bombings helped shape his decision to join the Army and specialise in bomb disposal, following a family tradition of military service. Bomb disposal science and training (Priority: 5/5): The discussion breaks down how explosive devices work, how ATOs are trained, and why defusing bombs depends on understanding their components, signatures, and threat environment. Operational deployments in Northern Ireland, Iraq, and Afghanistan (Priority: 5/5): Collett describes increasingly complex IED threats, intelligence fusion, counter-IED operations, and the shift from forensic collection to rapid neutralisation in Afghanistan to save lives. Forensic analysis and war-crime documentation (Priority: 4/5): He details post-retirement technical reporting for forensic architecture, including reverse-engineering blast damage from Beirut and Mariupol for legal and human-rights investigations. PTSD and mental health impacts of bomb disposal (Priority: 5/5): Collett discusses the psychological toll of repeated exposure to death, exhumations, inquests, and combat trauma, plus the difficulty of accessing support through the NHS and military systems. Cancer research and occupational health concerns (Priority: 5/5): Motivated by his own bladder cancer diagnosis, Collett investigates whether bomb-disposal veterans face elevated rates of bladder and other urological cancers due to toxic explosive precursors. Transition to academia and public-policy impact (Priority: 4/5): After leaving the Army, he becomes a lecturer and PhD researcher, helping shape UN/Interpol guidance on explosive precursors and training future ordnance specialists.
Key Arguments: Bomb disposal is a science-led profession: safely neutralising devices requires detailed knowledge of how they are made, powered, and triggered. IED threats in Iraq and Afghanistan demanded network-level countermeasures, not just device disposal, because intelligence fusion could identify bomb-makers, suppliers, and financiers. In high-volume conflict zones like Afghanistan, rapid destruction of devices could be justified to protect troops, even if it reduced forensic recovery. Blast-damage analysis can provide persuasive evidence in war-crime and human-rights investigations by identifying munition type, platform, and likely intended target. PTSD among bomb-disposal veterans is significant and long-lasting, and existing support systems have often been fragmented or hard to access. Preliminary occupational-health data suggest bladder cancer may be elevated among bomb-disposal personnel, warranting larger epidemiological studies and policy action. Chemical precursor regulation can reduce bomb-making capability, but regulation must be global and continuously updated as attackers adapt. Educational work with the UN and Interpol can improve border, port, and police detection of hazardous precursors before they are converted into explosives.
Data Points: Military career length: 32 years - Collett’s Army service before retirement Ammunition Technical Officer course length: 14 months - Specialist training required for bomb disposal qualification Exams on ATO course: 52 - Tests required during the 14-month qualification period Pass rate for high-threat course: 8% - Quoted pass rate for those attending the Northern Ireland high-threat course in his day Personnel sample size: 688 - Former service members contacted for the bladder-cancer survey Maximum potential squadron sample: 2,300 - Maximum size of the high-end bomb-disposal squadron cohort since 1970 Bladder cancer cases in survey: 12 - Diagnosed among the 688 respondents in Collett’s study Total urological cancers in survey: 44 - All urological cancer diagnoses among the 688 respondents Counter-IED teams in Iraq: 147 multinational teams - Teams working across Iraq during Collett’s deployment IEDs dealt with in Iraq: 67,000 - Volume of improvised explosive devices addressed over the period Collett describes Year PTSD intensified: 2000 - Collett links the exhumation of mass graves in Kosovo to the start of his PTSD Year of Iraq deployment: 2006 - Sent to assist the US Army as an IED specialist Year of defense attaché posting: 2015 - Diplomatic posting to Iraq where he learned Arabic Year of retirement: 2018 - He retired three years early from the Army Year of academic appointment: 2022 - Started as senior lecturer at University of Wales Trinity St David Year of cancer diagnosis: 2023 - Collett’s bladder cancer diagnosis, now in remission
Pivotal Quotes: "It was the day of the Hyde Park and Regent Park bombings." — Dr. Gareth Collett: Explaining the event that helped inspire his decision to join the Army and help people in bomb-threat situations "So, if the device was placed, we would then use various kinds of detector to find it. ... But ultimately, the best thing that we ever used was dogs." — Dr. Gareth Collett: Describing counter-IED methods in Iraq and the value of canine detection "I think in the year 2000 in Kosovo, I was responsible for making sure that the exhumation of mass graves were done effectively. That was one of my roles. And I think that's what started my PTSD for real." — Dr. Gareth Collett: Discussing the origins and development of his post-traumatic stress disorder
Implications: The episode shows how military engineering can inform public safety, forensic investigation, and cancer-risk research. It also argues for better PTSD support, stronger chemical regulation, and larger occupational-health studies for bomb-disposal veterans.
About The Life Scientific
Professor Jim Al-Khalili talks to leading scientists about their life and work, finding out what inspires and motivates them and asking what their discoveries might do for us in the future